We are live on ! Find out more
HOOK

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

32 hedge funds and large institutions have $5.3M invested in HOOKIPA Pharma in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $5K | Put options by funds: $3K

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

4.56% less ownership

Funds ownership: 55.35%50.79% (-4.6%)

16% less funds holding

Funds holding: 3832 (-6)

51% less capital invested

Capital invested by funds: $10.7M → $5.3M (-$5.45M)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
9
Reduced
6
Closed
10
Calls
$5K
Puts
$3K
Net Calls
+$2K
Net Calls Change
-$40K

HOOK Hedge Fund Activity: Q1 2025 in Review

32 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q1 2025, worth a combined $5.3M — down 51% from $10.7M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HOOK and 4 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $144K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $782K sold.

  • 32 institutional investors held HOOKIPA Pharma (HOOK) as of Q1 2025, down from 38 in Q4 2024.
  • Funds reported $5.3M of HOOKIPA Pharma stock for Q1 2025, down 51% quarter-over-quarter.
  • 4 funds opened new HOOKIPA Pharma positions in Q1 2025 and 10 closed out, a net change of -6 holders.
  • The largest HOOKIPA Pharma buyer in Q1 2025 was Vanguard Group, an estimated $144K added.
  • The largest HOOKIPA Pharma seller in Q1 2025 was EcoR1 Capital, an estimated $782K sold.

Based on aggregated 13F filings for Q1 2025.